AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACTINOGEN MEDICAL LTD

0.043

+0.0024.88%

Volume:3.37M

Turnover:144.83K

Market Cap:160.77M

PE:-9.32

High:0.044

Open:0.042

Low:0.042

Close:0.041

52wk High:0.072

52wk Low:0.026

Shares:3.74B

Float Shares:2.61B

Volume Ratio:2.09

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.005

EPS(LYR):-0.005

ROE:-77.46%

ROA:-35.71%

PB:7.52

PE(LYR):-9.35

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+0.60%

Capital Flow

Inflow:

Outflow:

News

Actinogen Medical (ASX:ACW) Shares Face Funding Pressure As Losses Deepen

Simply Wall St.

Actinogen Medical Ltd - FY Loss from Ordinary Activities After Tax Attributable A$15.4 Mln

THOMSON REUTERS

Actinogen Medical Ltd - no Dividends Declared in Current or Prior Year

THOMSON REUTERS

Actinogen Medical Advances Oral Enzyme Inhibitor for Potential Alzheimer's Disease Treatment

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/ACW.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACW.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","market":"AU","secType":"STK","nameCN":"ACTINOGEN MEDICAL LTD","latestPrice":0.043,"timestamp":1788329520000,"preClose":0.041,"halted":0,"volume":3371727,"delay":0,"changeRate":0.04878048780487792,"nameEN":"ACTINOGEN MEDICAL LTD","floatShares":2607880613,"shares":3738927748,"eps":-0.004615,"marketStatus":"Closed","change":0.002,"latestTime":"09-02 16:12:00 AEST","open":0.042,"high":0.044,"low":0.042,"amount":144831,"amplitude":0.04878,"askPrice":0.044,"askSize":171257,"bidPrice":0.043,"bidSize":1115813,"shortable":3,"etf":0,"ttmEps":-0.004615,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788393600000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.041,"openAndCloseTimeList":[[1788307200000,1788328800000]],"volumeRatio":2.093711,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ACW.AU","preClose":0.041,"auctionPrice":0.042,"auctionVolume":758211,"auctionTime":1788328804956,"referencePrice":0.043,"referenceTime":1788331320265,"auction":3,"marketStatus":"盘后竞价","timestamp":1788328804956}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","floatShares":2607880613,"roa":"-35.71%","roe":"-77.46%","lyrEps":-0.0046,"volumeRatio":2.093711,"shares":3738927748,"dividePrice":0,"high":0.044,"amplitude":0.04878,"preClose":0.041,"low":0.042,"week52Low":0.026,"pbRate":"7.52","psRate":"12.69","week52High":0.072,"institutionHeld":0,"latestPrice":0.043,"committee":0.733881,"eps":-0.004615,"divideRate":0,"volume":3371727,"delay":0,"ttmEps":-0.004615,"open":0.042,"prevYearClose":0.061,"prevWeekClose":0.044,"prevMonthClose":0.043,"prevQuarterClose":0.031,"fiveDayClose":0.044,"twentyDayClose":0.043,"sixtyDayClose":0.034,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACW.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-10-19","symbol":"ACW.AU","defaultRemindTime":1603062000000,"type":"split","dateTimestamp":1603026000000,"forFactor":98,"toFactor":100,"ratio":0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACW.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACW.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663701921","title":"Actinogen Medical (ASX:ACW) Shares Face Funding Pressure As Losses Deepen","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701921","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701921?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:28","pubTimestamp":1787948898,"startTime":"0","endTime":"0","summary":"Actinogen Medical entered this earnings season as a high risk biotech stock with a thin cash cushion and an unprofitable track record. The share price now trades at A$0.044 after a weak 7 day run and a stronger 3 month climb. The headline from this FY 2026 release is the pressure on the balance sheet. Management reported a loss of A$15.4 million over the trailing 12 months with no clear profitability in view and less than one year of cash runway.\nConcerned by Actinogen Medical's cash runway...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-acw/actinogen-medical-shares/news/actinogen-medical-asxacw-shares-face-funding-pressure-as-los","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-acw/actinogen-medical-shares/news/actinogen-medical-asxacw-shares-face-funding-pressure-as-los","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","ACW.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662773768","title":"Actinogen Medical Ltd - FY Loss from Ordinary Activities After Tax Attributable A$15.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662773768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662773768?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:29","pubTimestamp":1787812170,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","ACW.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662067773","title":"Actinogen Medical Ltd - no Dividends Declared in Current or Prior Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2662067773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662067773?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:29","pubTimestamp":1787812170,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0EI:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","ACW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657457083","title":"Actinogen Medical Advances Oral Enzyme Inhibitor for Potential Alzheimer's Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657457083","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657457083?lang=en_us&edition=fundamental","pubTime":"2026-08-06 08:34","pubTimestamp":1785976497,"startTime":"0","endTime":"0","summary":"Actinogen Medical  presented Xanamem, an oral enzyme inhibitor that lowers brain cortisol levels by blocking the 11β-HSD1 enzyme, at the Bioshares Biotech Summit in New Zealand, according to a Thursday filing with the Australian bourse.The company is advancing Xanamem for the potential treatment of Alzheimer's disease by blocking excess stress hormone cortisol production in brain cells, the filing said.The company anticipates top-line results from the fully enrolled phase 2b/3 XanaMIA pivotal trial in November, following independent Data Monitoring Committee recommendation in January that the trial continue unchanged, per the filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","ACW.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ACW.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.005961}]}}